{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:52:12Z","timestamp":1788187932160,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Project of Medicine Discipline of Guangzhou","award":["No.2021-2023-11"],"award-info":[{"award-number":["No.2021-2023-11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis B virus (HBV) infection is highly prevalent in Guangzhou, China. This study aimed to examine the long-term trend of HB incidence from 2008 to 2022 and the independent impacts of age, period, and cohort on the trends. HBV data were collected from the China Information System for Disease Control and Prevention. Joinpoint regression was utilized to examine temporal trends, and an age-period-cohort model was employed to estimate the effects of age, period, and cohort. A total of 327,585 HBV cases were included in this study. The incidence of chronic and acute HB showed a decreasing trend in Guangzhou over the past 15 years, with an average annual percent change of \u2212\u20094.31% and \u2212\u200916.87%, respectively. Age, period, and cohort all exerted significant effects. The incidence of HB was higher in males than in females and non-central areas compared to central areas. Age groups of 0\u20134 years and 15\u201324 years were identified as high-risk groups. The period relative risks for chronic HB incidence decreased initially and then stabilized. Cohorts born later had lower risks. Chronic HB incidences remain high in Guangzhou, especially among males, younger individuals, and residents of non-central areas. More efforts are still needed to achieve hepatitis elimination targets.<\/jats:p>","DOI":"10.1038\/s41598-024-63796-0","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T05:02:28Z","timestamp":1718082148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trends and age-period-cohort effect on incidence of hepatitis B from 2008 to 2022 in Guangzhou, China"],"prefix":"10.1038","volume":"14","author":[{"given":"Zhiwei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoubin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"issue":"3","key":"63796_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu, J., Liang, W., Jing, W. & Liu, M. Countdown to 2030: Eliminating hepatitis\u00a0B disease, China. Bull. World Health Organ. 97(3), 230\u2013238 (2019).","journal-title":"Bull. World Health Organ."},{"key":"63796_CR2","unstructured":"World Health Organization. Hepatitis B. 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 19 July 2023."},{"key":"63796_CR3","unstructured":"World Health Organization. 2016. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06. Accessed 19 July 2023."},{"issue":"1","key":"63796_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Hepatitis B infection in the general population of China: A systematic review and meta-analysis. BMC Infect. Dis. 19(1), 811 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"47","key":"63796_CR5","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","volume":"27","author":"X Liang","year":"2009","unstructured":"Liang, X. et al. Epidemiological serosurvey of hepatitis B in China\u2013declining HBV prevalence due to hepatitis B vaccination. Vaccine 27(47), 6550\u20136557 (2009).","journal-title":"Vaccine"},{"issue":"6","key":"63796_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"D Razavi-Shearer","year":"2018","unstructured":"Razavi-Shearer, D. et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modeling study. Lancet Gastroenterol. Hepatol. 3(6), 383\u2013403 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"6","key":"63796_CR7","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang, F. S., Fan, J. G., Zhang, Z., Gao, B. & Wang, H. Y. The global burden of liver disease: The major impact of China. Hepatology 60(6), 2099\u20132108 (2014).","journal-title":"Hepatology"},{"issue":"6","key":"63796_CR8","first-page":"6","volume":"42","author":"QY Yang","year":"2021","unstructured":"Yang, Q. Y. et al. Comparative analysis on seroprevalence of hepatitis B in Guangzhou in 2008 and 2018. Chin. J. Epidemiol. [in Chinese] 42(6), 6 (2021).","journal-title":"Chin. J. Epidemiol. [in Chinese]"},{"issue":"20","key":"63796_CR9","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.3390\/ijerph16203886","volume":"16","author":"W Ji","year":"2019","unstructured":"Ji, W. et al. Age-period-cohort analysis on the time trend of hepatitis B incidence in four prefectures of Southern Xinjiang, China from 2005 to 2017. Int. J. Environ. Res. Public Health 16(20), 3886 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"63796_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2147\/CLEP.S389853","volume":"14","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Liu, Y., Zhao, H. & Wang, G. Global patterns and trends in total burden of hepatitis B from 1990 to 2019 and predictions to 2030. Clin. Epidemiol. 14, 1519\u20131533 (2022).","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"63796_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12889-023-15130-y","volume":"23","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Changing incidence of hepatitis B and persistent infection risk in adults: A population-based follow-up study from 2011 in China. BMC Public Health 23(1), 256 (2023).","journal-title":"BMC Public Health"},{"issue":"8","key":"63796_CR12","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1537-2995.2009.02195.x","volume":"49","author":"S Zou","year":"2009","unstructured":"Zou, S. et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 49(8), 1609\u20131620 (2009).","journal-title":"Transfusion"},{"issue":"3","key":"63796_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/trf.16250","volume":"61","author":"WR Steele","year":"2021","unstructured":"Steele, W. R. et al. HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men. Transfusion 61(3), 839\u2013850 (2021).","journal-title":"Transfusion"},{"issue":"6","key":"63796_CR14","first-page":"466","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi, G. et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol. 4(6), 466\u2013476 (2019).","journal-title":"Lancet Gastroenterol."},{"issue":"4","key":"63796_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1253\/circj.CJ-19-0803","volume":"84","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Peng, Q., Guo, J., Zhou, L. & Lu, W. Age-period-cohort analysis of type-specific stroke morbidity and mortality in China. Circ. J. 84(4), 662\u2013669 (2020).","journal-title":"Circ. J."},{"key":"63796_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.842088","volume":"9","author":"X Su","year":"2022","unstructured":"Su, X. et al. Secular trends of acute viral hepatitis incidence and mortality in China, 1990 to 2019 and its prediction to 2030: The global burden of disease study 2019. Front. Med. 9, 842088 (2022).","journal-title":"Front. Med."},{"issue":"10","key":"63796_CR17","first-page":"1","volume":"9","author":"OB Ahmad","year":"2001","unstructured":"Ahmad, O. B., Boschi-Pinto, C. & Lopez, A. D. Age standardization of rates: A new WHO standard. Geneva World Health Organ. 9(10), 1\u201314 (2001).","journal-title":"Geneva World Health Organ."},{"issue":"3","key":"63796_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim, H. J., Fay, M. P., Feuer, E. J. & Midthune, D. N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19(3), 335\u2013351 (2000).","journal-title":"Stat. Med."},{"issue":"11","key":"63796_CR19","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg, P. S., Check, D. P. & Anderson, W. F. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol. Biomark. Prev. 23(11), 2296\u20132302 (2014).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"63796_CR20","doi-asserted-by":"publisher","first-page":"1008598","DOI":"10.3389\/fpubh.2022.1008598","volume":"10","author":"B Zhu","year":"2022","unstructured":"Zhu, B. et al. Trend dynamics of gout prevalence among the Chinese population, 1990\u20132019: A joinpoint and age-period-cohort analysis. Front. Public Health 10, 1008598 (2022).","journal-title":"Front. Public Health"},{"key":"63796_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ijid.2022.06.017","volume":"122","author":"T Yue","year":"2022","unstructured":"Yue, T. et al. Trends in the disease burden of HBV and HCV infection in China from 1990\u20132019. Int. J. Infect. Dis. 122, 476\u2013485 (2022).","journal-title":"Int. J. Infect. Dis."},{"issue":"5","key":"63796_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3201\/eid2305.161477","volume":"23","author":"F Cui","year":"2017","unstructured":"Cui, F. et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg. Infect. Dis. 23(5), 765\u2013772 (2017).","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"63796_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1086\/599332","volume":"200","author":"X Liang","year":"2009","unstructured":"Liang, X. et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992\u20132005 in China. J. Infect. Dis. 200(1), 39\u201347 (2009).","journal-title":"J. Infect. Dis."},{"issue":"11","key":"63796_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063482","volume":"12","author":"D Ndububa","year":"2022","unstructured":"Ndububa, D. et al. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria. BMJ Open 12(11), e63482 (2022).","journal-title":"BMJ Open"},{"issue":"1","key":"63796_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","volume":"67","author":"S Schillie","year":"2018","unstructured":"Schillie, S. et al. Prevention of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices. MMWR Recomm. Rep. 67(1), 1\u201331 (2018).","journal-title":"MMWR Recomm. Rep."},{"issue":"48","key":"63796_CR26","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1016\/j.vaccine.2015.09.011","volume":"33","author":"H Zheng","year":"2015","unstructured":"Zheng, H. et al. An economic analysis of adult hepatitis B vaccination in China. Vaccine 33(48), 6831\u20136839 (2015).","journal-title":"Vaccine"},{"issue":"1","key":"63796_CR27","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1038\/s41467-021-26475-6","volume":"12","author":"MJ de Villiers","year":"2021","unstructured":"de Villiers, M. J., Nayagam, S. & Hallett, T. B. The impact of the timely birth dose vaccine on the global elimination of hepatitis B. Nat. Commun. 12(1), 6223 (2021).","journal-title":"Nat. Commun."},{"issue":"36","key":"63796_CR28","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1016\/j.vaccine.2017.07.039","volume":"35","author":"H He","year":"2017","unstructured":"He, H., Zhou, Y. & Xie, S. Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005\u20132015. Vaccine 35(36), 4702\u20135470 (2017).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63796-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T05:04:36Z","timestamp":1718082276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["63796"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-63796-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13370"}}